Skip to content

Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery

Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02634957
Enrollment
17
Registered
2015-12-18
Start date
2016-01-31
Completion date
2020-01-31
Last updated
2020-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Neoplasm of True Vocal Cords

Keywords

phonomicrosurgery, benign vocal fold lesions, voice rest, vhi-10, CPP

Brief summary

Absolute voice rest is commonly prescribed after vocal fold surgery, also known as phonomicrosurgery, for benign vocal fold lesions. This is thought to decrease scarring of vocal folds, which could result in increasing tissue stiffness and limitations in optimal vocal outcome. Unfortunately there is no standardized protocol as to how long patients should rest their voice after phonomicrosurgery. To date, there are no studies in the literature directly comparing the impact of short-term and long-term voice rest on vocal fold healing and voice outcome after phonomicrosurgery.

Detailed description

The purpose of this study is to determine whether 3 days versus 7 days of absolute voice rest will result in different voice outcomes in patients who have undergone phonomicrosurgery for benign vocal fold lesions.

Interventions

absolute voice rest is the complete elimination of any vocalization (no sounds, speaking or whispering)

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients with benign mid membranous vocal fold lesions such as the following: 1. Polyps 2. Cysts 3. Sub-epithelial fibrous mass 2. Undergoing elective phonomicrosurgery for vocal fold lesions, which involves microflap excision +/- truncation +/- steroid injection into the vocal folds. 3. Age 18 and older

Exclusion criteria

Patients with any of the following will be excluded from the study: 1. Reinke's edema 2. Active smokers 3. Ligamentous mid membranous vocal fold lesions 4. RRP (Recurrent Respiratory Papillomatosis) 5. Dysplasia 6. CIS (Carcinoma-in-situ) 7. SCC (squamous cell carcinoma) 8. Extent of surgery exceeds what is mentioned in the inclusion criteria (e.g., CO2 laser, balloon dilatation, vocal fold augmentation in addition to phonomicrosurgery) 9. Previous vocal fold surgery 10. Systemic steroids 11. History of systemic illness that could affect wound healing

Design outcomes

Primary

MeasureTime frame
Voice Handicap Index - 103 months post op

Secondary

MeasureTime frame
Cepstral Peak Prominence (CPP)1 month and 3 months post op
Average phonatory airflow in all voiced sentence1 month and 3 months post op
video stroboscopy findings1 month and 3 months post op

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026